Literature DB >> 10377138

Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.

S Giguère1, M K Hondalus, J A Yager, P Darrah, D M Mosser, J F Prescott.   

Abstract

Rhodococcus equi is a facultative intracellular pathogen of macrophages and a cause of pneumonia in young horses (foals) and immunocompromised people. Isolates of R. equi from pneumonic foals typically contain large, 85- or 90-kb plasmids encoding a highly immunogenic virulence-associated protein (VapA). The objective of this study was to determine the role of the 85-kb plasmid and VapA in the intracellular survival and virulence of R. equi. Clinical isolates containing the plasmid and expressing VapA efficiently replicated within mouse macrophages in vitro, while plasmid-cured derivatives of these organisms did not multiply intracellularly. An isolate harboring the large plasmid also replicated in the tissues of experimentally infected mice, whereas its plasmid-cured derivative was rapidly cleared. All foals experimentally infected with a plasmid-containing clinical isolate developed severe bronchopneumonia, whereas the foals infected with its plasmid-cured derivative remained asymptomatic and free of visible lung lesions. By day 14 postinfection, lung bacterial burdens had increased considerably in foals challenged with the plasmid-containing clinical isolate. In contrast, bacteria could no longer be cultured from the lungs of foals challenged with the isogenic plasmid-cured derivative. A recombinant, plasmid-cured derivative expressing wild-type levels of VapA failed to replicate in macrophages and remained avirulent for both mice and foals. These results show that the 85-kb plasmid of R. equi is essential for intracellular replication within macrophages and for development of disease in the native host, the foal. However, expression of VapA alone is not sufficient to restore the virulence phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377138      PMCID: PMC116543     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens.

Authors:  A S Fernandez; J F Prescott; V M Nicholson
Journal:  Vet Microbiol       Date:  1997-06-16       Impact factor: 3.293

Review 2.  The large virulence plasmid of Shigella.

Authors:  C Sasakawa; J M Buysse; H Watanabe
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  Sequence of the Rhodococcus equi gene encoding the virulence-associated 15-17-kDa antigens.

Authors:  T Sekizaki; S Takai; Y Egawa; T Ikeda; H Ito; S Tsubaki
Journal:  Gene       Date:  1995-03-21       Impact factor: 3.688

4.  Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: temperature-dependent expression and location of the antigens.

Authors:  S Takai; M Iie; Y Watanabe; S Tsubaki; T Sekizaki
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  Experimental subacute foal pneumonia induced by aerosol administration of Corynebacterium equi.

Authors:  R J Martens; R A Fiske; H W Renshaw
Journal:  Equine Vet J       Date:  1982-04       Impact factor: 2.888

6.  Virulence of Rhodococcus equi isolates from patients with and without AIDS.

Authors:  S Takai; Y Sasaki; T Ikeda; Y Uchida; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  Virulence-associated plasmids in Rhodococcus equi.

Authors:  S Takai; Y Watanabe; T Ikeda; T Ozawa; S Matsukura; Y Tamada; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Survival and replication of Rhodococcus equi in macrophages.

Authors:  M K Hondalus; D M Mosser
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  The effect of experimental infection with Rhodococcus equi on immunodeficient mice.

Authors:  J A Yager; C A Prescott; D P Kramar; H Hannah; G A Balson; B A Croy
Journal:  Vet Microbiol       Date:  1991-08-30       Impact factor: 3.293

10.  Influence of a 70 kilobase virulence plasmid on the ability of Yersinia enterocolitica to survive phagocytosis in vitro.

Authors:  S N Tabrizi; R M Robins-Browne
Journal:  Microb Pathog       Date:  1992-09       Impact factor: 3.738

View more
  69 in total

1.  DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103.

Authors:  S Takai; S A Hines; T Sekizaki; V M Nicholson; D A Alperin; M Osaki; D Takamatsu; M Nakamura; K Suzuki; N Ogino; T Kakuda; H Dan; J F Prescott
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Internally controlled real-time PCR method for quantitative species-specific detection and vapA genotyping of Rhodococcus equi.

Authors:  David Rodríguez-Lázaro; Deborah A Lewis; Alain A Ocampo-Sosa; Ursula Fogarty; László Makrai; Jesús Navas; Mariela Scortti; Marta Hernández; José A Vázquez-Boland
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins.

Authors:  B A Byrne; J F Prescott; G H Palmer; S Takai; V M Nicholson; D C Alperin; S A Hines
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Authors:  A Marianela Lopez; Melissa T Hines; Guy H Palmer; Debra C Alperin; Stephen A Hines
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals.

Authors:  G Muscatello; J R Gilkerson; G F Browning
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

6.  The intracellular pathogen Rhodococcus equi produces a catecholate siderophore required for saprophytic growth.

Authors:  Raúl Miranda-CasoLuengo; John F Prescott; José A Vázquez-Boland; Wim G Meijer
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

7.  The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodococcus equi ATCC 33701.

Authors:  Dean A Russell; Gavin A Byrne; Enda P O'Connell; Clara A Boland; Wim G Meijer
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

8.  IcgA is a virulence factor of Rhodococcus equi that modulates intracellular growth.

Authors:  Xiaoguang Wang; Garry B Coulson; Aleksandra A Miranda-Casoluengo; Raúl Miranda-Casoluengo; Mary K Hondalus; Wim G Meijer
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

9.  Transcriptional regulation of the virR operon of the intracellular pathogen Rhodococcus equi.

Authors:  Gavin A Byrne; Dean A Russell; Xiaoxiao Chen; Wim G Meijer
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.